Start-up funding sources and biotechnology firm growth

Applied Economics Letters

Volumn 16, Issue 13, 2009, Pages 1341-1345

  Ahmed, Shamim ^a   Cozzarin, Brian P ^b  

^a BANGLADESH BANK   (Bangladesh)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CAPITAL FORMATION; FIRM SIZE; GROWTH RATE; RESEARCH AND DEVELOPMENT;

EID: 70349581487     PISSN: 13504851     EISSN: 14664291     Source Type: Journal    
DOI: 10.1080/13504850701367338     Document Type: Article

References (7)

1. Hall, B. H., Mairesse, J., Branstetter, L. and Crepon, B. (1998) Does cash flow cause investment and R&D: an exploration using panel data for French, Japanese, and United States scientific firms, University of California at Berkeley, Working Paper, January.
2. Jeng, L. A. and Wells, P. C. (2000) The determinants of venture capital funding: evidence across countries, Journal of Corporate Finance, 6, 241-89.
3. Jensen, M. C. (1993) Presidential address: the modern industrial revolution, exit and failure of internal control systems, Journal of Finance, 48, 831-80.
4. Myers, S. C. and Majluf, N. S. (1984) Corporate financing and investment decisions when firms have information that investors do not have, Journal of Financial Economics, 13, 187-221.
5. Statistics Canada (2001a) Biotechnology use and development survey 2001, Science, Innovation and Electronic Information Division, 2001.
6. Statistics Canada (2001b) Practices and activities of Canadian biotechnology firms: results from the biotechnology use and development survey 1999, Science, Innovation and Electronic Information Division, Cat. No. 88FOOO6XIEO1O11.
7. Traore, N. (2005) Access to financing capital by Canadian innovative biotechnology firms. Science, Innovation and Electronic Information Division, Canada, Cat. No. 88F0006XIE - No. 010.